Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2013
11/21/2013WO2013171505A2 In vivo guided selection & antibodies
11/21/2013WO2013171289A1 Combination of cd37 antibodies with further agents
11/21/2013WO2013171287A1 Combination of cd37 antibodies with ice (ifosfamide, carboplatin, etoposide)
11/21/2013WO2013171268A1 Allergen variants
11/21/2013WO2013171156A1 Recombinant bacterial host cell for protein expression
11/21/2013WO2013170977A1 Stabilised protein solutions
11/21/2013WO2013170779A1 Pharmaceutical composition comprising anti-vegf antibody
11/21/2013WO2013158276A8 Antibody binding microbial heparin binding motif to retard or prevent microbial biofilm formation on implanted medical devices
11/21/2013WO2013144566A3 Animals expressing human lambda immunoglobulin light chain variable domain
11/21/2013WO2013138522A3 Methods for assessing effectiveness and monitoring oncolytic virus treatment
11/21/2013WO2013122513A3 Nanobodies which bind to the chlamydia trachomatis antigen and method for inhibiting infection caused by chlamydia trachomatis
11/21/2013WO2013106577A3 Enhancement of transport of therapeutic molecules across the blood brain barrier
11/21/2013WO2013104804A3 Dual antigen-induced bipartite functional complementation
11/21/2013WO2013084147A3 Antibodies for epidermal growth factor receptor 3 (her3)
11/21/2013WO2013003625A4 Antibodies to adp-ribosyl cyclase 2
11/21/2013WO2012135831A8 Cell-penetrating anti-dna antibodies and uses thereof to inhibit dna repair
11/21/2013WO2005042743A8 Humanization of antibodies
11/21/2013US20130310543 Toxin genes and methods for their use
11/21/2013US20130310542 Inotropic Effects of Antibodies on Cardiac Contraction
11/21/2013US20130310541 Use of an anti-tau ps422 antibody for the treatment of brain diseases
11/21/2013US20130310317 Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including igf-ir
11/21/2013US20130310281 Novel antigen binding proteins
11/21/2013US20130309251 Protofibril-Binding Antibodies And Their Use In Therapeutic And Diagnostic Methods For Parkinson's Disease, Dementia With Lewy Bodies And Other Alpha-Synucleinopathies
11/21/2013US20130309250 Cancer immunotherapy by disrupting pd-1/pd-l1 signaling
11/21/2013US20130309248 Human binding molecules capable of neutralizing influenza virus h3n2 and uses thereof
11/21/2013US20130309240 Compositions and Methods including a Recombinant Human MAB that Promotes CNS Remyelination
11/21/2013US20130309239 Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (trem-1)
11/21/2013US20130309237 Pathogenic Mycobacteria-Derived Mannose-Capped Lipoarabinomannan Antigen Binding Proteins
11/21/2013US20130309236 Anti-interferon-alpha antibodies
11/21/2013US20130309235 Antagonists of il-17a, il-17f, and il-23p19
11/21/2013US20130309233 Antigen Binding Proteins that Bind EGFR
11/21/2013US20130309232 Vascular endothelial growth factor 2
11/21/2013US20130309231 Methods for using taci-immunoglobulin fusion proteins
11/21/2013US20130309230 Modified Antibody Compositions, Methods of Making and Using Thereof
11/21/2013US20130309227 Methods for targeting pulmonary diseases with agents that bind a target in pulmonary tissue
11/21/2013US20130309223 CD33 Antibodies And Use Of Same To Treat Cancer
11/21/2013US20130309194 Inhibition of il-17 production
11/21/2013US20130309179 Synthetic peptide constructs for the diagnosis and treatment of periodontis associated with porphyromonas gingivalis
11/21/2013US20130306000 Aflaxtoxin Resistant Poultry
11/21/2013DE102012010209A1 Enrichment of antigen-specific memory-B cells for production of recombinant monoclonal antibodies, comprises magnetic separation with magnetic-bound antigen, from the blood of vertebrates e.g. humans
11/20/2013EP2664680A1 Antibody-based methods of diagnosing infections with lymphocytic choriomeningitis virus (LCMV)
11/20/2013EP2664668A1 Induction of flocculation in photosynthetic organisms
11/20/2013EP2664625A2 Blood-brain barrier permeable peptide compositions
11/20/2013EP2664624A1 Allergen variants
11/20/2013EP2664346A1 Anti-sclerostin antibodies
11/20/2013EP2663643A1 Methods for the identification and repair of amino acid residues destabilizing single-chain variable fragments (scfv)
11/20/2013EP2663580A1 Combination therapy including tumor associated antigen binding antibodies
11/20/2013EP2663579A2 Therapeutic antibodies against ror-1 protein and methods for use of same
11/20/2013EP2663578A2 Il-27 antagonists for treating inflammatory diseases
11/20/2013EP2663577A1 Antibody molecules which bind il-17a and il-17f
11/20/2013EP2663334A2 Antibodies directed against influenza
11/20/2013EP2663333A2 Stem cell factor inhibitor
11/20/2013EP2663329A2 Tlr3 binding agents
11/20/2013EP2411047B1 Vaccine for protection against streptococcus suis bacteria of various serotypes
11/20/2013EP2292767B1 Polypepdides having DNA polymerase activity
11/20/2013EP2292766B1 Polypeptides having DNA polymerase activity
11/20/2013EP2281005B1 Single domain antibodies capable of modulating bace1 activity
11/20/2013EP2272869B1 Angiopoietin-2 specific binding agents
11/20/2013EP2235052B1 Proteinaceous binding molecules comprising purification tags
11/20/2013EP2207885B1 Quadruple transgenic non-human animal
11/20/2013EP2205640B1 Antibodies that bind il-4 and/or il-13 and their uses
11/20/2013EP2203478B1 Compositions and methods for use of antibodies against sclerostin
11/20/2013EP2177611B1 Method for measurement of concentration of antigen
11/20/2013EP2089428B1 Crystalline anti-htnfalpha antibodies
11/20/2013EP2075334B1 EG-VEGF nucleic acids and polypeptides and methods of use
11/20/2013EP1841794B1 Adam-9 modulators
11/20/2013EP1765396B1 Anti-psgl-1 antibodies
11/20/2013CN103403550A Means and methods for diagnosing cancer using an antibody which specifically binds to BRAF V600E
11/20/2013CN103403030A Methods for treating and diagnosing disease
11/20/2013CN103403029A CEA antibodies
11/20/2013CN103403028A Antibody specifically binding synovial microvasculature of arthritis patients
11/20/2013CN103403027A Fibronectin cradle molecules and libraries thereof
11/20/2013CN103403026A Neutralizing antibodies to HIV-1 and their use
11/20/2013CN103403025A Monovalent antigen binding proteins
11/20/2013CN103403020A Novel alkali-resistant variants of protein a and their use in affinity chromatography
11/20/2013CN103402533A Use of amino acid sequences from mycobacterium tuberculosis or corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefrom.
11/20/2013CN103397041A Cytolethal distending toxinand detection of campylobacter bacteria with cytolethal distending toxin as target
11/20/2013CN103396494A Monoclonal antibody of blood coagulation factor IX
11/20/2013CN103396493A Preparation method for monoclonal antibodies with functions of anti-tumor angiogenesis
11/20/2013CN103396492A Human platelet collagen receptor resistant human-derived monoclonal antibody fragment and application thereof
11/20/2013CN103396491A Monoclonal antibodies against human anti-mullerian hormone type II receptor (AMHR-II), and manufacturing method thereof and application
11/20/2013CN103396490A Anti CD37 antibodies
11/20/2013CN103396489A Engineered anti-IL-23p19 antibodies
11/20/2013CN103396488A Anti-IGF antibodies
11/20/2013CN103396487A Anti-IGF antibodies
11/20/2013CN103396486A Diagnosis and treatment of cancer using anti-EREG antibody
11/20/2013CN103396485A Method and composition for targeting polyubiquitin
11/20/2013CN103396484A Single-chain antibody for detecting tetracycline, its coding gene and application
11/20/2013CN103396483A Antigen associated with rheumatoid arthritis
11/20/2013CN103396482A Prealbumin nano-antibody, and coding sequence and application thereof
11/20/2013CN103396481A Heavy chain single-domain antibody of type-II dengue fever virus NS1 protein as well as preparation method and application of heavy chain single-domain antibody
11/20/2013CN103396480A Antibody purification process
11/20/2013CN103394084A Immunoglobulin G (IgG) concentrate depleted of anti-A and anti-B antibodies and of polyreactive IgGs
11/20/2013CN103394083A Monomethylvaline compounds capable of conjugation to ligands
11/20/2013CN103393601A Microspheres comprising protein and showing injectability at high concentration of protein
11/20/2013CN102702349B Bactrian camel VHH (variable domain of the heavy chain of HACbs) heavy-chain antibody for resisting foot-and-mouth disease AsiaI type viruses, preparation method and use thereof
11/20/2013CN102532309B Colloid gold test strip for detecting porcine reproductive and respiratory syndrome antibody
11/20/2013CN102286102B Method for preparing sodium-potassium adenosine triphosphatase (ATP) DR domain specific antibody and medicinal effect thereof in treatment of kidney ischemia-reperfusion injury
11/20/2013CN101460195B Methods for treating conditions associated with masp-2 dependent complement activation
11/19/2013US8586723 Genomic morse code
1 ... 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 ... 1494